Targeting the PARP10-BCAT2 axis disrupts branched-chain amino-acid metabolism to suppress bone metastasis in lung cancer
Yahan Qin, Ke Xue, Yujian Xu, Hongyu Pan, Wenjun Chai, Lei Sun, Xiaoli Liu, Jing Li, Yue Cao, Jing Li, Qian Liu, Mingxia Yan · 2026
Read Targeting the PARP10-BCAT2 axis disrupts branched-chain amino-acid metabolism to suppress bone metastasis in lung cancer by Yahan Qin, Ke Xue, Yujian Xu, Hongyu Pan, Wenjun Chai, Lei Sun, Xiaoli Liu, Jing Li, Yue Cao, Jing Li, Qian Liu, Mingxia Yan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13526790.txt.
Description
Yahan Qin and colleagues identify, in a 2026 study, an enzyme called PARP10 as a driver of lung cancer spread to bone, a complication marked by resistance and severe illness. Sequencing of bone metastases across cancers found PARP10 consistently raised, and high levels in primary tumors tracked with poor survival. The team probed how it works.
Removing PARP10 damaged tumor DNA, raised oxidative stress, and switched on a second enzyme, BCAT2, under control of the MYC regulator, boosting breakdown of branched-chain amino acids. That shift fed tumor energy production yet starved the bone environment of those amino acids, suppressing the bone-eating cells that metastasis needs. A PARP10-blocking drug shrank bone metastatic burden in mice without visible toxicity, attacking tumor cells and their niche together.
Catalog record
| CREATOR | Yahan Qin, Ke Xue, Yujian Xu, Hongyu Pan, Wenjun Chai, Lei Sun, Xiaoli Liu, Jing Li, Yue Cao, Jing Li, Qian Liu, Mingxia Yan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 103358 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |